Proof-of-concept studies were performed in 2008 when tumor-derived exosomes were enriched by a modified magnetic activated cell sorting procedure, using anti-epithelial cell adhesion molecule (EpCAM) [17]. This evidence concerns the gene EPCAM and neoplasm.